Takeda Pharmaceutical Company Limited is a global, research-driven biopharmaceutical company based in Japan. Founded in 1781, the company discovers, develops, manufactures, and markets prescription medicines and vaccines. Its core therapeutic areas include gastroenterology and inflammation, oncology, neuroscience, rare genetic and hematology diseases, plasma-derived therapies, and vaccines.
Takeda operates an international R&D and manufacturing network that spans small‑molecule and biologic modalities. Capabilities include medicinal chemistry, process and scale-up chemistry, biologics development and production, plasma fractionation, and formulation and fill‑finish. The company produces active pharmaceutical ingredients (APIs) and finished dosage forms for global markets, supplying healthcare systems in numerous countries. Its activities intersect with the broader chemical value chain through API synthesis, process development, quality control, and compliance with global cGMP and regulatory standards.
Official website: takeda.com
chemXplore tracks active investment projects involving Takeda, across sectors such as Basic Chemicals, Biobased & Circular, and Polymers.
Takeda's role is mapped on each — as Owner, Investor / Financier, Operator, Developer, and more.
To provide comprehensive coverage, we aggregate data and news under the name Takeda, encompassing the following company names, divisions, and related entities:
武田薬品, Takeda Pharmaceuticals, 武田薬品工業株式会社, Takeda Yakuhin Kōgyō kabushiki gaisha, Takeda Yakuhin Kōgyō Kabushiki Kaisha, and Takeda China.
This list encompasses current and former names, alternate names, and key divisions associated with Takeda, ensuring you can easily find all relevant information under a single, unified profile.
